Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia.
Saved in:
| Title: | Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia. |
|---|---|
| Authors: | Wiggers CRM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Cho EY; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ozdemir M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bamgbose G; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Hegel J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Frede J; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Warlitz F; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Heavican-Foral TB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Pop I; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Shraim R; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Pölönen P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Koch V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Tran TH; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Teachey DT; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA., Bledsoe JR; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Harris MH; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA., Silverman LB; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY, USA., Lohr JG; Harvard Medical School, Boston, MA, USA. jens.lohr@hci.utah.edu.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. jens.lohr@hci.utah.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jens.lohr@hci.utah.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. jens.lohr@hci.utah.edu., Knoechel B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. birgit.knoechel@hci.utah.edu.; Harvard Medical School, Boston, MA, USA. birgit.knoechel@hci.utah.edu.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. birgit.knoechel@hci.utah.edu.; Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. birgit.knoechel@hci.utah.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. birgit.knoechel@hci.utah.edu. |
| Source: | Nature communications [Nat Commun] 2025 Nov 21; Vol. 16 (1), pp. 10263. Date of Electronic Publication: 2025 Nov 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41271691 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wiggers+CRM%22">Wiggers CRM</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cho+EY%22">Cho EY</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ozdemir+M%22">Ozdemir M</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Bamgbose+G%22">Bamgbose G</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Hegel+J%22">Hegel J</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Frede+J%22">Frede J</searchLink>; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Warlitz+F%22">Warlitz F</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Heavican-Foral+TB%22">Heavican-Foral TB</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pop+I%22">Pop I</searchLink>; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Shraim+R%22">Shraim R</searchLink>; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Pölönen+P%22">Pölönen P</searchLink>; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Koch+V%22">Koch V</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tran+TH%22">Tran TH</searchLink>; Division of Pediatric Hematology-Oncology, Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Mullighan+CG%22">Mullighan CG</searchLink>; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.<br /><searchLink fieldCode="AU" term="%22Teachey+DT%22">Teachey DT</searchLink>; Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bledsoe+JR%22">Bledsoe JR</searchLink>; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Pikman+Y%22">Pikman Y</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Harris+MH%22">Harris MH</searchLink>; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Place+AE%22">Place AE</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Silverman+LB%22">Silverman LB</searchLink>; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lohr+JG%22">Lohr JG</searchLink>; Harvard Medical School, Boston, MA, USA. jens.lohr@hci.utah.edu.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. jens.lohr@hci.utah.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. jens.lohr@hci.utah.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. jens.lohr@hci.utah.edu.<br /><searchLink fieldCode="AU" term="%22Knoechel+B%22">Knoechel B</searchLink>; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. birgit.knoechel@hci.utah.edu.; Harvard Medical School, Boston, MA, USA. birgit.knoechel@hci.utah.edu.; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. birgit.knoechel@hci.utah.edu.; Department of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA. birgit.knoechel@hci.utah.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. birgit.knoechel@hci.utah.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Nov 21; Vol. 16 (1), pp. 10263. <i>Date of Electronic Publication: </i>2025 Nov 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41271691 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-025-65134-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 10263 Titles: – TitleFull: Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wiggers CRM – PersonEntity: Name: NameFull: Cho EY – PersonEntity: Name: NameFull: Ozdemir M – PersonEntity: Name: NameFull: Bamgbose G – PersonEntity: Name: NameFull: Hegel J – PersonEntity: Name: NameFull: Frede J – PersonEntity: Name: NameFull: Warlitz F – PersonEntity: Name: NameFull: Heavican-Foral TB – PersonEntity: Name: NameFull: Pop I – PersonEntity: Name: NameFull: Shraim R – PersonEntity: Name: NameFull: Pölönen P – PersonEntity: Name: NameFull: Koch V – PersonEntity: Name: NameFull: Tran TH – PersonEntity: Name: NameFull: Mullighan CG – PersonEntity: Name: NameFull: Teachey DT – PersonEntity: Name: NameFull: Bledsoe JR – PersonEntity: Name: NameFull: Pikman Y – PersonEntity: Name: NameFull: Harris MH – PersonEntity: Name: NameFull: Place AE – PersonEntity: Name: NameFull: Silverman LB – PersonEntity: Name: NameFull: Lohr JG – PersonEntity: Name: NameFull: Knoechel B IsPartOfRelationships: – BibEntity: Dates: – D: 21 M: 11 Text: 2025 Nov 21 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |